T1 is emerging as a quantitative MR biomarker of liver fibrosis, the most important histological change predictive of progressing chronic liver disease. 3D spoiled gradient echo (SGRE)-based T1 mapping is preferable in the abdomen for its short acquisition time, volumetric coverage, and robustness to motion. However, SGRE-based T1 mapping is confounded by tissue fat and B1 inhomogeneity. In this work we present a novel SGRE-based T1 mapping method that corrects for both fat and B1 inhomogeneity. Phantom experiments show excellent agreement with reference T1 values (slope=1.01, R2=1.00) and minimal bias (~5±23ms). Early results from 5 healthy volunteers are promising.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords